USPTO serial 88144611
DTECT ALL
Reviewed by CopyMark Law Group
Reg. 5941360Status 710
- Filing date
- Status date
- Registration date
- Dec 24, 2019
- Examiner
- HUNT, LEE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with DTECT ALL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ILLKIRCH-GRAFFENSTADEN, FR
ILLKIRCH-GRAFFENSTADEN, FR
ILLKIRCH-GRAFFENSTADEN, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey M. Goehring
Jeffrey M. Goehring Nixon & Vanderhye P.C.901 N. Glebe Road, 11th FloorArlington, VA 22203UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical additives used in the biotechnology and pharmaceutical industries; Chemicals used for biotechnology industry; Chemicals used for biological purposes in the field of industry; biological preparations for use in biotechnological industry and science; Chemical reagents, other than for medical or veterinary purpose | SECTION 8 - CANCELLED | — |
| 005 | Chemical preparations used in the pharmaceutical industries for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; Chemicals used for biological purposes in the medical field; Chemicals used in the medical and veterinary industries; biological preparations for use in the medical and veterinary industries for the treatment of cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; biological preparations for use in the pharmaceutical industry for medical treatment of cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; biological preparations for use in pharmaceuticals industry in the field of industry and science; Pharmaceutical and veterinary pharmaceutical preparations for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; medical or biological diagnostic tests for diagnosing cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; medical or biological diagnostic tests for the identification of molecules for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases | SECTION 8 - CANCELLED | — |
| 009 | Scientific apparatus and instruments, for the measurement of biological, pharmacological, psychological or chemical phenomena, namely, for measuring interactions between chemicals, molecules, proteins, antibodies and peptides with their targets | SECTION 8 - CANCELLED | — |
| 042 | Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discovering, identifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic use | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Domain Therapeutics
- Other trademarks owned by Domain Therapeutics
- Other trademarks owned by Domain Therapeutics
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named DTECT ALL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 10, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 24, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 23, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 23, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 23, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 23, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 24, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 19, 2019 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Sep 30, 2019 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Sep 30, 2019 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Aug 16, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jul 30, 2019 | INOA | AMENDMENT AFTER NOA NOT ENTERED | — |
| Jul 30, 2019 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 16, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 21, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 21, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 1, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2019 | ALIE | ASSIGNED TO LIE | — |
| Mar 22, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 19, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 19, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 19, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 18, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 18, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 25, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 25, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 17, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 17, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 16, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 9, 2018 | NWAP | NEW APPLICATION ENTERED | — |